However, in tumor variants with a high intrinsic tumor level of PI3K/Akt/mTOR, MFP as a single agent did not induce tumor regression, and its combination with PI3K/mTOR inhibitors is required to induce a therapeutic response. Here, AKT1 is linked to neoplasm.